Notes - Segment Information, Etc.

ASKA Pharmaceutical Holdings CO., Ltd. - Filing #7328356

Concept 2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
Notes - Segment information, etc.
Segment information
Disclosure of sales, profit (loss), asset, liability, and other items for each reportable segment
Sales
Revenues from external customers
56,016,000,000 JPY
62,843,000,000 JPY
162,000,000 JPY
JPY
62,843,000,000 JPY
6,664,000,000 JPY
6,660,000,000 JPY
53,579,000,000 JPY
60,461,000,000 JPY
220,000,000 JPY
JPY
60,461,000,000 JPY
Transactions with other segments
JPY
JPY
64,000,000 JPY
-64,000,000 JPY
64,000,000 JPY
JPY
JPY
JPY
77,000,000 JPY
77,000,000 JPY
-77,000,000 JPY
JPY
Other items
Depreciation
2,227,000,000 JPY
2,432,000,000 JPY
JPY
201,000,000 JPY
2,231,000,000 JPY
4,000,000 JPY
4,000,000 JPY
2,487,000,000 JPY
2,491,000,000 JPY
JPY
481,000,000 JPY
2,972,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.